BLACK PEARL EXTENDS TENDER OFFER FOR ALL OUTSTANDING SHARES OF SELECTIS HEALTH, INC.
Black Pearl Equities extended its tender offer for all outstanding shares of Selectis Health, Inc. (OTCQB: GBCS), a healthcare company, at $5.75 per share in cash. The offer, initially set to expire on August 27, 2026, has been extended to August 31, 2026. As of the previous deadline, 2,786,482 shares had been validly tendered. The extension aims to satisfy certain conditions for the offer's consummation.
How this was made
The 30-second read
Why it matters
The tender extension provides additional time for shareholders to decide, potentially altering the deal's success probability and affecting GBCS's market liquidity.
Market read
Primary disclosure of a tender extension for a micro‑cap healthcare OTC stock; relevant for traders monitoring M&A activity in the sector.
What to watch
Potential regulatory approvals and financing risks that could derail the transaction.
Background
Selectis Health operates skilled nursing and assisted living facilities in the US Southeast. Black Pearl is a private investment firm focusing on healthcare.
Ticker impact
Black Pearl extended its tender offer for Selectis Health, Inc. (GBCS) to Aug 31, 2026, providing shareholders more time to tender shares at $5.75 each.
Potential modest upside if additional shareholders tender; downside risk if tender fails.
The extension signals continued interest but does not change price or terms; market reaction will depend on tender uptake.
Market effects
May influence other small-cap healthcare OTC stocks as tender activity signals consolidation interest.
Limited to US OTC market; no broader regional effect.
Low global relevance; confined to niche healthcare operators.
Counterpoint
The extension could indicate difficulties in securing enough tendered shares, suggesting a possible failure of the deal.
Key entities
- companySelectis Health, Inc.
Healthcare operator targeted by the tender offer.
- investment_firmBlack Pearl Equities
Sponsor of the tender offer.